Venous Thromboembolism in Patients with Ovarian Carcinoma Undergoing Neoadjuvant Chemotherapy or Primary Cytoreductive Surgery
Authors:
- Dib SassineDSDib Sassine
- Ling ChenLCLing Chen
- Erin McMinnEMErin McMinn
- Xiao XuXXXiao Xu
- Jason D. WrightJWJason D. Wright
- June Y. HouJHJune Y. Hou
- 27 October 2026
- journal article
- Published by Elsevier in International Journal of Gynecological Cancer
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Risk factors for venous thromboembolism in patients undergoing neoadjuvant chemotherapy as treatment for ovarian cancerEuropean Journal of Obstetrics & Gynecology and Reproductive Biology, 2024
- Venous thromboembolism during neoadjuvant chemotherapy for ovarian cancerInternational Journal of Gynecological Cancer, 2024
- Incidence of venous thromboembolism in patients with ovarian cancer receiving neoadjuvant chemotherapy: systematic review and meta-analysisInternational Journal of Gynecological Cancer, 2024
- Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: ASCO Guideline UpdateJournal of Clinical Oncology, 2023
- Assessing the need for venous thromboembolism prophylaxis at the time of neoadjuvant chemotherapy for ovarian cancer: A literature reviewGynecologic Oncology, 2023
- Risk of venous thromboembolism in ovarian cancer patients receiving neoadjuvant chemotherapyGynecologic Oncology, 2021
- Meta-Analysis of VTE Risk: Ovarian Cancer Patients by Stage, Histology, Cytoreduction, and Ascites at DiagnosisObstetrics and Gynecology International, 2020
- Safety and Efficacy of Apixaban vs Enoxaparin for Preventing Postoperative Venous Thromboembolism in Women Undergoing Surgery for Gynecologic Malignant NeoplasmJAMA Network Open, 2020
- Incidence and Timing of Thromboembolic Events in Patients With Ovarian Cancer Undergoing Neoadjuvant ChemotherapyObstetrics & Gynecology, 2017